- Public Health England
- Part of:
- Respiratory syncytial virus (RSV): guidance, data and analysis and Immunisation against infectious disease
- 20 March 2013
- Last updated:
- 4 September 2015, see all updates
Respiratory syncytial virus immunisation information for public health professionals, including updates.
PDF, 343KB, 11 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
Respiratory syncytial virus (RSV) is an enveloped RNA virus that belongs to the Paramyxoviridae family within the Pneumovirus genus. The virus has a non-segmented, single stranded, negative sense genome that encodes 11 proteins.
Published: 20 March 2013
Updated: 4 September 2015
- The chapter has been updated to provide clearer definitions of the groups in whom palivizumab use is advised. Revisions to the chapter also take into account the revised formulation of Synagis® as a solution for injection.
- First published.